Vident Advisory’s Cytokinetics CYTK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q4
Sell
-4,195
Closed -$221K 1473
2024
Q3
$221K Buy
+4,195
New +$221K 0.01% 1270